Author Information
Mohammed A. Dahab is affiliated with the Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt, and the Centre for Catalysis Research and Innovation, Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ontario, Canada. His research primarily focuses on medicinal chemistry, drug design, and the development of potential therapeutic agents targeting various biological pathways and diseases.Research Contributions
Mohammed A. Dahab has made significant contributions to the field of medicinal chemistry and drug design. His research includes the design, synthesis, and evaluation of various chemical compounds with potential therapeutic effects. Notably, he has worked extensively on developing inhibitors for VEGFR-2, which are crucial for cancer treatment, and investigating the inhibitory activities of compounds against SARS-CoV-2 and other viruses. His studies often involve comprehensive in silico modeling, molecular docking, and dynamics simulations to predict the efficacy and safety of these compounds.Aliases
Mohammed A. Dahab is also known by the following aliases: Mohammed A Dahab
Mohammed Dahab
Mohammed Galal Abu El Dahab
Publication and Citation Metrics
| Metric |
Value |
| Total Number of Papers |
32 |
| Total Citation Count |
549 |
| h-index |
12 |
